Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Hungary Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20103
20113
20121
20142
20163
20172
20183
20201
20212
20222
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
H. Lundbeck A/S4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AstraZeneca3
Intra-Cellular Therapies, Inc.2
Naurex, Inc, an affiliate of Allergan plc2
Neurocrine Biosciences2
Shire2
AbbVie1
Alkermes, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder28
Depressive Disorder3
Mental Disorders3
Mood Disorders3
Anhedonia2
Depressive Disorder, Treatment-Resistant1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.